A two-dimensional approach to study amyloid β-peptide fragment (25-35)

被引:14
|
作者
Triulzi, Robert C. [1 ]
Li, Changqing [1 ]
Naistat, David [1 ]
Orbulescu, Jhony [1 ]
Leblanc, Roger M. [1 ]
机构
[1] Univ Miami, Dept Chem, Coral Gables, FL 33146 USA
来源
JOURNAL OF PHYSICAL CHEMISTRY C | 2007年 / 111卷 / 12期
关键词
D O I
10.1021/jp0669005
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The neuritic plaques formed by amyloid beta-peptide (A beta) play a seminal role in the pathogenesis of Alzheimer's disease (AD). A beta sequence 25-35 (GSNKGAIIGLM) is among the most frequently studied A beta derivatives for the reason that it possesses the structural characteristic of A beta and remains neurotoxic. A beta(25-35) was modified with an aliphatic chain (C-18) at the N-terminal of the peptide for the study of the Langmuir monolayer at the air-water interface. The main advantage of the 2D approach is the self-assembly of the peptide moiety in the subphase, and therefore the aggregation process of the peptidolipid A beta(25-35) was monitored by surface pressure and surface potential-area isotherms. The real-time epifluorescence microscopy was utilized to observe the topography of the domains formed, whereas polarization modulation infrared reflection absorption spectroscopy (PM-IRRAS) provided the information on the structural features of the domains at the air-water interface. Langmuir-Blodgett films were prepared to examine by circular dichroism (CD) the conformation of the peptidolipid film in the domains.
引用
收藏
页码:4661 / 4666
页数:6
相关论文
共 50 条
  • [31] Interaction of Alzheimer's disease amyloid β peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain
    Pérez, M
    Cuadros, R
    Benítez, MJ
    Jiménez, JS
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2004, 6 (05) : 461 - 467
  • [32] Transforming growth factor-β inhibits apoptosis induced by β-amyloid peptide fragment 25-35 in cultured neuronal cells
    Kim, ES
    Kim, RS
    Ren, RF
    Hawver, DB
    Flanders, KC
    [J]. MOLECULAR BRAIN RESEARCH, 1998, 62 (02): : 122 - 130
  • [33] Single chain FV antibodies against 25-35 peptide fragment of amyloid-β:: Potential therapeutic for Alzheimers disease
    Zameer, A
    Liu, RT
    Sierks, M
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S593 - S593
  • [34] Phloretin affects oligomerization membrane activity of fragment 25-35 of β-amyloid peptide through dissolving ordered lipid domains
    Efimova, S.
    Ostroumova, O.
    [J]. FEBS JOURNAL, 2017, 284 : 152 - 152
  • [35] Effect of phospholipid membrane on conformation of retro-sequence amyloid-β-peptide 35-25 and normal amyloid-β-peptide 25-35
    Kodaka, M
    [J]. PROTEIN AND PEPTIDE LETTERS, 2001, 8 (05): : 395 - 398
  • [36] Effects of amyloid beta peptide (25-35) on the behavior of rats in a radial maze
    Stepanichev, MY
    Moiseeva, YV
    Lazareva, NA
    Gulyaeva, NV
    [J]. ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA, 2004, 54 (03) : 382 - 389
  • [37] Insertion of externally administered amyloid β peptide 25-35 and perturbation of lipid bilayers
    Dante, S
    Hauss, T
    Dencher, NA
    [J]. BIOCHEMISTRY, 2003, 42 (46) : 13667 - 13672
  • [38] Structure and membrane interactions of the β-amyloid fragment 25-35 as viewed using spectroscopic approaches
    Labbe, Jean-Franois
    Lefevre, Thierry
    Guay-Begin, Andree-Anne
    Auger, Michele
    [J]. PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2013, 15 (19) : 7228 - 7239
  • [39] Effects of docosahexaenoic acid on in vitro amyloid beta peptide 25-35 fibrillation
    Hashimoto, Michio
    Shahdat, Hossain Md
    Katakura, Masanori
    Tanabe, Yoko
    Gamoh, Shuji
    Miwa, Koji
    Shimada, Toshio
    Shido, Osamu
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2009, 1791 (04): : 289 - 296
  • [40] The amyloid β peptide Aβ (25-35) induces apoptosis independent of p53
    Blasko, I
    Wagner, M
    Whitaker, N
    Grubeck-Loebenstein, B
    Jansen-Dürr, P
    [J]. FEBS LETTERS, 2000, 470 (02) : 221 - 225